New hope for black lung? drug trial targets scarred lungs
NCT ID NCT05288179
First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tests if pirfenidone capsules can help people with pneumoconiosis, a lung disease caused by inhaling dust like coal or silica. About 272 adults with silicosis or coal worker's pneumoconiosis will receive either the drug or a placebo for 52 weeks. The main goal is to see if the drug slows the decline in lung function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCONIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing China-Japan Friendship Hospital
RECRUITINGBeijing, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.